GXAI.NASDAQGaxosai INC

10-Q: Gaxos.ai Inc. Reports First Quarter 2024 Results, Highlights Strategic Growth Initiatives

Sentiment:

Quarterly Report

📋All filings for Gaxosai INC
🔒Login to Follow

Gaxos.ai Inc. reported its first quarter 2024 financial results, showing a net loss but also highlighting progress in its gaming and health initiatives and a recent capital raise.

Capital raiseThe company completed a private placement on March 15, 2024, raising net proceeds of $3,056,984.The private placement involved the issuance of common stock, pre-funded warrants, and series A and B warrants to an institutional investor.The company intends to use the net proceeds for general corporate purposes and working capital.
Worse than expectedThe company's revenue of $19 is significantly below expectations for a public company.The company's net loss of $912,145 is worse than expected for a company that has been operating for several years.

Summary

  • Gaxos.ai Inc. reported a net loss of $912,145 for the three months ended March 31, 2024, compared to a net loss of $1,536,031 for the same period in 2023.
  • The company's revenue for the quarter was $19, a slight increase from no revenue in the same period last year.
  • Operating expenses decreased to $1,043,858 from $1,542,332 year-over-year, primarily due to a reduction in general and administrative costs.
  • Research and development expenses increased to $182,329 from $104,551, reflecting increased investment in the Gaxos Games and Gaxos Health platforms.
  • The company completed a private placement, raising net proceeds of $3,056,984 to support general corporate purposes and working capital.
  • As of March 31, 2024, Gaxos.ai had a cash balance of $3,312,277 and short-term investments of $2,092,078.
  • The company's working capital was $5,251,505 as of March 31, 2024.
  • Gaxos.ai launched four proprietary games in 2023 and plans to launch more in 2024.
  • The company is developing an AI solution for game developers, expected to launch in Q2 2024.
  • Gaxos Health, a new initiative focused on AI-powered health optimization, is expected to launch in the second half of 2024.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While the company has made progress in reducing losses and securing funding, it still faces significant challenges in generating revenue and achieving profitability. The focus on AI and new product development is positive, but the financial results are still weak.

Positives

  • The company's net loss decreased significantly year-over-year, indicating improved financial performance.
  • Operating expenses were reduced by 32.3%, showing better cost management.
  • The successful private placement raised over $3 million in net proceeds, strengthening the company's financial position.
  • The company is actively investing in research and development, which is crucial for future growth.
  • Gaxos.ai is expanding into the health sector with its Gaxos Health initiative, diversifying its business.
  • The company has a pipeline of games in development and plans to launch more in 2024.

Negatives

  • The company continues to operate at a loss, with a net loss of $912,145 for the quarter.
  • Revenue generation remains minimal, with only $19 in revenue for the quarter.
  • Research and development expenses increased by 74.4%, which may impact short-term profitability.
  • The company is still in the early stages of development and faces risks associated with launching new products and services.

Risks

  • The company's ability to obtain additional funds for operations is a significant risk.
  • The company's financial performance, including revenue generation and profitability, is uncertain.
  • The company faces competition from existing competitors and new market entrants.
  • The company's ability to manage growth and future expenses is a risk.
  • The company's ability to maintain, protect, and enhance its intellectual property is a risk.
  • The company's ability to comply with modified or new laws and regulations is a risk.
  • The company's ability to attract and retain qualified key management and technical personnel is a risk.

Future Outlook

The company expects to continue to generate operating losses in the foreseeable future until it implements its growth strategy. It believes its existing working capital and cash on hand will be sufficient to meet its operating needs for the next twelve months. The company plans to launch an AI solution for game developers in Q2 2024 and an AI-powered health optimization product in the second half of 2024.

Management Comments

  • The company is committed to addressing the need for AI solutions in both health and entertainment.
  • The company believes that its AI-powered health optimization technology is a leap forward in empowering individuals to take control of their health and longevity.
  • The company plans to methodically launch games based on research and market data.

Industry Context

The company's focus on AI in gaming and health aligns with current industry trends, where AI is increasingly being used to enhance user experiences and personalize services. The development of NFT-based in-game assets also reflects the growing interest in blockchain technology within the gaming industry. The company's move into health with AI-powered solutions is a strategic diversification that taps into the growing demand for personalized health and wellness technologies.

Comparison to Industry Standards

  • Gaxos.ai's revenue of $19 is significantly lower than established gaming companies like Activision Blizzard or Electronic Arts, which generate billions in revenue per quarter.
  • The company's net loss of $912,145 is typical for early-stage tech companies focused on R&D, but it is important to compare this to similar companies in the AI and gaming space, such as Unity Technologies or Roblox, which have varying levels of profitability.
  • The company's focus on AI-powered solutions is similar to other tech companies like Google or Microsoft, but Gaxos.ai is targeting niche markets in gaming and health.
  • The company's private placement of $3,056,984 is a common funding method for early-stage companies, but the amount is relatively small compared to venture capital funding rounds of larger tech startups.
  • The company's development of NFT-based in-game assets is similar to other blockchain gaming projects like Axie Infinity or Decentraland, but Gaxos.ai's approach to AI integration is a differentiating factor.

Stakeholder Impact

  • Shareholders may be concerned about the company's continued losses and minimal revenue generation.
  • Employees may be encouraged by the company's investment in R&D and new product development.
  • Customers may be interested in the company's new AI-powered gaming and health solutions.
  • Suppliers and creditors may be cautious due to the company's ongoing losses and reliance on external funding.

Next Steps

  • The company plans to launch an AI solution for game developers in Q2 2024.
  • The company plans to launch an AI-powered health optimization product in the second half of 2024.
  • The company plans to launch more games in 2024.
  • The company will continue to pursue its plans with respect to the research and development of its products.

Key Dates

DateDescription
October 27, 2021Gaxos.ai Inc. was incorporated in Wyoming.
March 30, 2022The company reincorporated to the State of Delaware.
March 30, 2022The company's Board of Directors authorized and adopted the 2022 Equity Incentive Plan.
August 29, 2022The company entered into a Software and Patent License Agreement with Columbia University.
February 17, 2023The company completed its initial public offering (IPO).
February 17, 2023The company entered into an executive employment agreement with Vadim Mats.
March 20, 2023The Board of Directors approved a stock repurchase program.
August 9, 2023The company and Columbia University agreed to terminate the License Agreement, effective August 1, 2023.
January 5, 2024The company changed its name from The NFT Gaming Company, Inc. to Gaxos.ai Inc.
January 9, 2024The company was notified that it had not regained compliance with Nasdaq listing rules.
January 16, 2024The company's request to appeal the delisting determination was received, staying the suspension of its securities.
February 28, 2024A majority of shareholders granted discretionary authority to the Board of Directors to effect a reverse stock split.
March 4, 2024The company entered into a Purchase Agreement to acquire certain technology and computer code.
March 5, 2024The company granted stock options to its board of directors.
March 7, 2024The company filed a Certificate of Amendment to effect a 1-for-12 reverse stock split.
March 7, 2024The company entered into Advisory Board Agreements with three members of the Medical Advisory Board.
March 13, 2024The company entered into a securities purchase agreement for a private placement.
March 15, 2024The private placement closed.
March 22, 2024The company received notice that it regained compliance with Nasdaq minimum bid price requirements.
March 31, 2024End of the first quarter of 2024.
May 10, 2024There were 1,093,672 shares of common stock issued and outstanding.
May 14, 2024The date of the filing of the Quarterly Report on Form 10-Q.

Keywords

AI, Gaming, Health, NFT, Artificial Intelligence, Game Development, Private Placement, Software Development, Financial Results, Gaxos Gaming, Gaxos Health

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.